Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer

Michael J. Baine, Vivek Verma, Caitlin A. Schonewolf, Chi Lin, Charles B. Simone

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Contrary to prevailing notions of uniform efficacy regarding stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report has indicated increased risk of local failure for squamous cell carcinoma (SCC). As those data have not been corroborated by other studies, we performed a multi-institutional analysis to evaluate the influence of histology on post-SBRT outcomes. Materials and methods: Records from 152 consecutive patients who received SBRT for primary early-stage NSCLC at two academic medical centers were retrospectively assessed. Primary comparison was between SCC and adenocarcinoma. Patient outcomes including actuarial recurrences and overall survival were calculated using the Kaplan-Meier method. Univariable and multivariable logistic regression analyses addressed associated factors. Results: At a median follow-up of 44 months, patients with SCC had an increased risk of local, (hazard ratio (HR) (95% confidence interval (CI)): 1.69 (1.05–2.73), p = 0.032), regional (HR (95% CI): 2.03 (1.24–3.33), p = 0.005), and distant failure (HR (95% CI): 1.71 (1.06–2.77), p = 0.036). Median times to local (32 m vs 50m, p = 0.023), regional (26 m vs 50 m, p = 0.011), and distant (26 m vs 50 m, p = 0.024) failure were all significantly reduced in SCC histology. SCC histology was also independently associated with an increased risk for death (HR: 1.80 (1.10–2.94), p = 0.019) and had a 5-yr overall survival of 26%, versus 41% for adenocarcinoma (p = 0.016). Conclusions: This multi-institutional analysis corroborates that SCC histology is independently predictive for local, regional, and distant recurrence and worse overall survival. Future data are needed to determine if treatment paradigms should differ by histology for early stage NSCLC.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalLung Cancer
Volume118
DOIs
StatePublished - Apr 2018

Fingerprint

Non-Small Cell Lung Carcinoma
Squamous Cell Carcinoma
Histology
Radiotherapy
Recurrence
Survival
Confidence Intervals
Adenocarcinoma
Logistic Models
Regression Analysis

Keywords

  • Histology
  • Non-small cell lung cancer
  • Squamous cell carcinoma
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer. / Baine, Michael J.; Verma, Vivek; Schonewolf, Caitlin A.; Lin, Chi; Simone, Charles B.

In: Lung Cancer, Vol. 118, 04.2018, p. 20-26.

Research output: Contribution to journalArticle

Baine, Michael J. ; Verma, Vivek ; Schonewolf, Caitlin A. ; Lin, Chi ; Simone, Charles B. / Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer. In: Lung Cancer. 2018 ; Vol. 118. pp. 20-26.
@article{1f4483c6ddb84ea488a179c63ab32c76,
title = "Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer",
abstract = "Background: Contrary to prevailing notions of uniform efficacy regarding stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report has indicated increased risk of local failure for squamous cell carcinoma (SCC). As those data have not been corroborated by other studies, we performed a multi-institutional analysis to evaluate the influence of histology on post-SBRT outcomes. Materials and methods: Records from 152 consecutive patients who received SBRT for primary early-stage NSCLC at two academic medical centers were retrospectively assessed. Primary comparison was between SCC and adenocarcinoma. Patient outcomes including actuarial recurrences and overall survival were calculated using the Kaplan-Meier method. Univariable and multivariable logistic regression analyses addressed associated factors. Results: At a median follow-up of 44 months, patients with SCC had an increased risk of local, (hazard ratio (HR) (95{\%} confidence interval (CI)): 1.69 (1.05–2.73), p = 0.032), regional (HR (95{\%} CI): 2.03 (1.24–3.33), p = 0.005), and distant failure (HR (95{\%} CI): 1.71 (1.06–2.77), p = 0.036). Median times to local (32 m vs 50m, p = 0.023), regional (26 m vs 50 m, p = 0.011), and distant (26 m vs 50 m, p = 0.024) failure were all significantly reduced in SCC histology. SCC histology was also independently associated with an increased risk for death (HR: 1.80 (1.10–2.94), p = 0.019) and had a 5-yr overall survival of 26{\%}, versus 41{\%} for adenocarcinoma (p = 0.016). Conclusions: This multi-institutional analysis corroborates that SCC histology is independently predictive for local, regional, and distant recurrence and worse overall survival. Future data are needed to determine if treatment paradigms should differ by histology for early stage NSCLC.",
keywords = "Histology, Non-small cell lung cancer, Squamous cell carcinoma, Stereotactic body radiation therapy",
author = "Baine, {Michael J.} and Vivek Verma and Schonewolf, {Caitlin A.} and Chi Lin and Simone, {Charles B.}",
year = "2018",
month = "4",
doi = "10.1016/j.lungcan.2018.01.021",
language = "English (US)",
volume = "118",
pages = "20--26",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer

AU - Baine, Michael J.

AU - Verma, Vivek

AU - Schonewolf, Caitlin A.

AU - Lin, Chi

AU - Simone, Charles B.

PY - 2018/4

Y1 - 2018/4

N2 - Background: Contrary to prevailing notions of uniform efficacy regarding stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report has indicated increased risk of local failure for squamous cell carcinoma (SCC). As those data have not been corroborated by other studies, we performed a multi-institutional analysis to evaluate the influence of histology on post-SBRT outcomes. Materials and methods: Records from 152 consecutive patients who received SBRT for primary early-stage NSCLC at two academic medical centers were retrospectively assessed. Primary comparison was between SCC and adenocarcinoma. Patient outcomes including actuarial recurrences and overall survival were calculated using the Kaplan-Meier method. Univariable and multivariable logistic regression analyses addressed associated factors. Results: At a median follow-up of 44 months, patients with SCC had an increased risk of local, (hazard ratio (HR) (95% confidence interval (CI)): 1.69 (1.05–2.73), p = 0.032), regional (HR (95% CI): 2.03 (1.24–3.33), p = 0.005), and distant failure (HR (95% CI): 1.71 (1.06–2.77), p = 0.036). Median times to local (32 m vs 50m, p = 0.023), regional (26 m vs 50 m, p = 0.011), and distant (26 m vs 50 m, p = 0.024) failure were all significantly reduced in SCC histology. SCC histology was also independently associated with an increased risk for death (HR: 1.80 (1.10–2.94), p = 0.019) and had a 5-yr overall survival of 26%, versus 41% for adenocarcinoma (p = 0.016). Conclusions: This multi-institutional analysis corroborates that SCC histology is independently predictive for local, regional, and distant recurrence and worse overall survival. Future data are needed to determine if treatment paradigms should differ by histology for early stage NSCLC.

AB - Background: Contrary to prevailing notions of uniform efficacy regarding stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report has indicated increased risk of local failure for squamous cell carcinoma (SCC). As those data have not been corroborated by other studies, we performed a multi-institutional analysis to evaluate the influence of histology on post-SBRT outcomes. Materials and methods: Records from 152 consecutive patients who received SBRT for primary early-stage NSCLC at two academic medical centers were retrospectively assessed. Primary comparison was between SCC and adenocarcinoma. Patient outcomes including actuarial recurrences and overall survival were calculated using the Kaplan-Meier method. Univariable and multivariable logistic regression analyses addressed associated factors. Results: At a median follow-up of 44 months, patients with SCC had an increased risk of local, (hazard ratio (HR) (95% confidence interval (CI)): 1.69 (1.05–2.73), p = 0.032), regional (HR (95% CI): 2.03 (1.24–3.33), p = 0.005), and distant failure (HR (95% CI): 1.71 (1.06–2.77), p = 0.036). Median times to local (32 m vs 50m, p = 0.023), regional (26 m vs 50 m, p = 0.011), and distant (26 m vs 50 m, p = 0.024) failure were all significantly reduced in SCC histology. SCC histology was also independently associated with an increased risk for death (HR: 1.80 (1.10–2.94), p = 0.019) and had a 5-yr overall survival of 26%, versus 41% for adenocarcinoma (p = 0.016). Conclusions: This multi-institutional analysis corroborates that SCC histology is independently predictive for local, regional, and distant recurrence and worse overall survival. Future data are needed to determine if treatment paradigms should differ by histology for early stage NSCLC.

KW - Histology

KW - Non-small cell lung cancer

KW - Squamous cell carcinoma

KW - Stereotactic body radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85041676196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041676196&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2018.01.021

DO - 10.1016/j.lungcan.2018.01.021

M3 - Article

C2 - 29571997

AN - SCOPUS:85041676196

VL - 118

SP - 20

EP - 26

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -